Back
Kazia Therapeutics Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
21
KZIA
Kazia Therapeutics
Last Price:
$3.27
Seasonality Move:
-14.32%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and KZIA is experiencing slight selling pressure.
Kazia Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.45 | Buy |
20-day SMA: | 3.49 | Buy |
50-day SMA: | 3.78 | Sell |
200-day SMA: | 13.81 | Sell |
8-day EMA: | 3.54 | Buy |
20-day EMA: | 3.58 | Buy |
50-day EMA: | 4.48 | Sell |
200-day EMA: | 12.08 | Sell |
Kazia Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 49 | Sell |
Chaikin Money Flow: | -1243 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.31 - 3.75) | Buy |
Bollinger Bands (100): | (2.54 - 9.1) | Sell |
Kazia Therapeutics Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Kazia Therapeutics Stock
Is Kazia Therapeutics Stock a Buy?
-
Kazia Therapeutics share price is 3.64 while KZIA 8-day simple moving average is 3.45, which is a Buy signal.
-
The stock price of KZIA is 3.64 while Kazia Therapeutics 20-day SMA is 3.49, which makes it a Buy.
-
Kazia Therapeutics 50-day simple moving average is 3.78 while KZIA share price is 3.64, making it a Sell technically.
-
KZIA stock price is 3.64 and Kazia Therapeutics 200-day simple moving average is 13.81, creating a Sell signal.
KZIA Technical Analysis vs Fundamental Analysis
Sell
21
Kazia Therapeutics (KZIA)
is a Sell
Is Kazia Therapeutics a Buy or a Sell?
-
Kazia Therapeutics stock is rated a SellThe current Kazia Therapeutics [KZIA] share price is $3.64. The Score for KZIA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
Kazia Therapeutics Stock Info
Market Cap:
4.1M
Price in USD:
3.64
Share Volume:
3.4K
Kazia Therapeutics 52-Week Range
52-Week High:
79.00
52-Week Low:
2.86
Sell
21
Kazia Therapeutics (KZIA)
is a Sell
Kazia Therapeutics Share Price Forecast
-
What is the Kazia Therapeutics stock price today?The Kazia Therapeutics stock price is 3.64 USD today.
-
Will KZIA stock go up or go down?Kazia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Kazia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kazia Therapeutics is overvalued.
Is Kazia Therapeutics Stock a Buy?
-
Kazia Therapeutics share price is 3.64 while KZIA 8-day exponential moving average is 3.54, which is a Buy signal.
-
The stock price of KZIA is 3.64 while Kazia Therapeutics 20-day EMA is 3.58, which makes it a Buy.
-
Kazia Therapeutics 50-day exponential moving average is 4.48 while KZIA share price is 3.64, making it a Sell technically.
-
KZIA stock price is 3.64 and Kazia Therapeutics 200-day simple moving average is 12.08, creating a Sell signal.
Fundamental Analysis of Kazia Therapeutics
Is Kazia Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.08 per share.
Technical Analysis of Kazia Therapeutics
Should I short Kazia Therapeutics stock?
-
KZIA Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Kazia Therapeutics is a Sell
-
Kazia Therapeutics Relative Strength Index (RSI) is 49, which suggest Kazia Therapeutics is oversold
-
The Bollinger Bands (25) for Kazia Therapeutics is (3.31 - 3.75), which suggest Kazia Therapeutics is a Sell
-
The Bollinger Bands (100) for Kazia Therapeutics is (2.54 - 9.1), which suggest Kazia Therapeutics is a Sell
* Kazia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.